CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Hand-out
Press Releases
April 1, 2025

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

2024 marked by strong commercial execution and improved operating leverageCompany continues to expect DrugSorb-ATR regulatory decisions from Health Canada and US FDA in 2025Successful Rights Offering and exercise of Series

bradford

The Bradford Era

Local & Social